Clinical trial
Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women…
NCT00196404 · Duramed Research, Industry · Completed
Key facts
| NCT number | NCT00196404 |
|---|---|
| Title | Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder |
| Official title | A Multicenter, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder |
| Lead sponsor | Duramed Research, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Urinary Incontinence |
| Intervention type | Drug, Other |
| Interventions | DR-3001a, DR-3001b, Placebo |
| Enrollment | 800 |
| Start date | Oct 1, 2004 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 20, 2012 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: